Krilogy Financial LLC Biogen Inc. Transaction History

Krilogy Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 25, 2021	SELL	$282.99 - $369.05 $185,358 - $241,727	-655 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$259.0 - $414.71 $169,645 - $271,635	655 New	655 $227,000
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $150,390 - $190,485	-540 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $158,495 - $207,268	540 New	540 $191,000
Q2 2018 Aug 15, 2018	SELL	$257.52 - $306.91 $124,897 - $148,851	-485 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $27,833 - $39,366	107 Added 28.31%	485 $133,000
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $140,591 - $157,473	-457 Reduced 54.73%	378 $120,000
Q3 2017 Nov 15, 2017	BUY	$281.15 - $329.69 $141,980 - $166,493	505 Added 153.03%	835 $261,000
Q2 2017 Aug 15, 2017	BUY	N/A	330	330 $90,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.